AEGiS-AFROL: SA: Western Cape women receive free AIDS drugs afrol.comImportant note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
Click here to return to Afrol.com main menu
Print this Article


SA: Western Cape women receive free AIDS drugs

African Online Services (afrol.com), - February 12, 2001


While the South African government is under heavy critics for its unwillingness to provide preganant HIV positive women with drugs that prevent the transmission to their unborn children, the province Western Cape has cut several international deals, enabling it to provide these drugs freely.

Premier Peter Marais of Western Cape province is noted for his independent policies, himself being the only province leader not from the governing ANC party. Together with his party, the conservative Democratic Alliance (DA), he doesn't agree with President Mbeki's controversial stand on medical AIDS treatment. His provincial government has assured the first, free treatment programmes in South Africa.

Last month, Marais announced Western Cape was to receive five years of free nevirapine from the German-based pharmaceutical company Boehringer-Ingelheim. This would enable the province to treat between 5,000 and 6,000 HIV positive pregnant women, Marais told the press in Cape Town.

Marais announced the nevirapine would be made available to the 38 maternity facilities where the mother-to-child HIV treatment had been implemented. The anti-retroviral would also be distributed at all 101 baby clinics in the next few weeks.

H l ne Rossouw from the Western Cape government told afrol News the province would receive 5532 doses for the mothers and 5029 doses for the babies over the first contract year. Combining its own efforts and the donation, "the Province will have access to enough Nevirapine for all who need it," Rossouw said.

Boehringer-Ingelheim has offered all developing countries free Nevirapine for use in the MTCT programme for 5 years "with no strings attached," according to Rossouw. Applications are however reviewed according to several criteria.

The receiver has to document it posesses an adaquate programme of health care - especially antenatal care, care of mother and baby and infant feeding strategies - a logistic infrastructure to distribute the drug and a austainability of the programme after the 5 year period. "The Western Cape province's application was approved because it scored very highly on all the above criteria," Mrs Rossouw explained.

The Western Cape province was already committed to providing maternal-to-child transmission (MTCT) drugs to all pregnant women in the province before the Boehringer-Ingelheim deal. This had been also provided for in the province's 2002/2003 budget. "With this approval we will be able to re-direct over R250,000 which would have paid for the drug to the employment of extra staff and counsellors," Rossouw says.

Although the province now will have access to enough Nevirapine for all who need it, the drug will be immediately available to all. According to Rossouw, the drug will be made available according to the Province's roll out programme prioritising areas of high prevalence. "Following a systematic roll out programme will ensure that the women have access to the full package of care which includes Voluntary Counselling and Testing, counselling for feeding options and the free supply of formula for those mothers choosing to formula feed."

Reactions to the Western Cape's deal with Boehringer-Ingelheim have generally been positive, also by the Treatment Action Campaign (TAC), which is leading the campaigns in South Africa to ensure access to HIV and AIDS treatment. The organisation however had a few "reservations".

TAC executive secretary Nonkosi Khumalo told Eric Ntabazalila from the 'Cape Times'; "Donations by pharmaceutical companies usually have strings attached. It's good and we welcome the donation but Boehringer-Ingelheim must provide voluntary licences to generic companies so that there will be competition and the drugs would be cheaper".

Rossouw answers TAC's reservations by maintianing ,"There are absolutely no strings attached to the Nevirapine donation for use in MTCT." The province only had to to provide a progress report to Boeringer-Ingelheim twice a year.

Meanwhile, in Pretoria, TAC has filed a new application at the High Court in the case concerning the right of pregnant women with HIV to have access to Nevirapine on a national scale. TAC is seeking the court to order the immediate execution of an important part of its original judgement, which has been appealed by the national government. The relevant part concerns the order that the state "make Nevirapine available ... in public health facilities."

Asked to comment on the national government's policy on providing free Nevrapine, Rossouw only states; "Health is a provincial competence." Peter Marais has also been careful critisicing the national government directly, but has made it clear there could "be no talk about development when our children are dying of HIV and AIDS."
020212
AO020201


Copyright © 2002 - afrol News. All rights reserved. Reproducing or buying afrol News' articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .